PMC:7029759 / 8651-8867 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"201","span":{"begin":47,"end":52},"obj":"Species"},{"id":"202","span":{"begin":118,"end":126},"obj":"Species"},{"id":"212","span":{"begin":201,"end":210},"obj":"Species"}],"attributes":[{"id":"A201","pred":"tao:has_database_id","subj":"201","obj":"Tax:4932"},{"id":"A202","pred":"tao:has_database_id","subj":"202","obj":"Tax:9606"},{"id":"A212","pred":"tao:has_database_id","subj":"212","obj":"Tax:2697049"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"er organisms for protein expression (bacteria, yeast, insect cells) would facilitate faster production of therapy for patients 19.\nAn alternative strategy of generating neutralizing antibodies against 2019-nCoV S pro"}

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T106","span":{"begin":3,"end":12},"obj":"NCBITaxon:1"},{"id":"T105","span":{"begin":17,"end":24},"obj":"BV_20"},{"id":"T104","span":{"begin":25,"end":35},"obj":"BV_20;GO:0010467"},{"id":"T103","span":{"begin":37,"end":45},"obj":"NCBITaxon:2"},{"id":"T102","span":{"begin":54,"end":60},"obj":"NCBITaxon:6960"},{"id":"T101","span":{"begin":182,"end":192},"obj":"GO:0042571"},{"id":"T100","span":{"begin":201,"end":210},"obj":"SP_7"}],"text":"er organisms for protein expression (bacteria, yeast, insect cells) would facilitate faster production of therapy for patients 19.\nAn alternative strategy of generating neutralizing antibodies against 2019-nCoV S pro"}

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T33","span":{"begin":17,"end":24},"obj":"Body_part"},{"id":"T34","span":{"begin":61,"end":66},"obj":"Body_part"}],"attributes":[{"id":"A33","pred":"fma_id","subj":"T33","obj":"http://purl.org/sig/ont/fma/fma67257"},{"id":"A34","pred":"fma_id","subj":"T34","obj":"http://purl.org/sig/ont/fma/fma68646"}],"text":"er organisms for protein expression (bacteria, yeast, insect cells) would facilitate faster production of therapy for patients 19.\nAn alternative strategy of generating neutralizing antibodies against 2019-nCoV S pro"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T70","span":{"begin":3,"end":12},"obj":"http://purl.obolibrary.org/obo/OBI_0100026"},{"id":"T71","span":{"begin":3,"end":12},"obj":"http://purl.obolibrary.org/obo/UBERON_0000468"},{"id":"T72","span":{"begin":37,"end":45},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_2"},{"id":"T73","span":{"begin":61,"end":66},"obj":"http://purl.obolibrary.org/obo/GO_0005623"}],"text":"er organisms for protein expression (bacteria, yeast, insect cells) would facilitate faster production of therapy for patients 19.\nAn alternative strategy of generating neutralizing antibodies against 2019-nCoV S pro"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T20","span":{"begin":17,"end":24},"obj":"Chemical"}],"attributes":[{"id":"A20","pred":"chebi_id","subj":"T20","obj":"http://purl.obolibrary.org/obo/CHEBI_36080"}],"text":"er organisms for protein expression (bacteria, yeast, insect cells) would facilitate faster production of therapy for patients 19.\nAn alternative strategy of generating neutralizing antibodies against 2019-nCoV S pro"}